This analysis provides an initial look at how PEPFAR is currently defining and approaching sustained epidemic control at the country level.
- view as grid
- view as list
This fact sheet reviews current national and state policies around Emergency Contraception, including methods, patient awareness, access and availability, and insurance coverage. Among methods discussed are ulipristal acetate (ella), intrauterine devices (copper IUDs and levonorgestrel IUDs), and progestin-based pills (Plan B and Next Choice).
Abortion Access Rises as a Voting Issue and Motivator, Especially Among Democrats and Reproductive-Age Women, But Inflation Continues to Dominate as Americans Worry About Bills
Following the Supreme Court’s decision to end the constitutional right to an abortion, most voters (55%) now say access to abortion is “very important” to their vote in November’s midterm elections, up 9 percentage points since February prior to the decision, a new KFF Health Tracking Poll finds. This heightened…
KFF Health Tracking Poll July 2022: Inflation Tops Voters’ Priorities, But Abortion Access Resonates For Key Voting Blocs
This poll finds most voters (55%) now say access to abortion is “very important” to their vote in November’s midterm elections, up since the Supreme Court decision overturning Roe v. Wade. This heightened interest is greatest among voter groups who largely want to guarantee access to abortion, including Democratic voters and women voters under 50 years old.
Long COVID has been described as our “next national health disaster” and the “pandemic after the pandemic,” but we know little about how many people are affected, how long it will last for those affected, and how it could change employment and health coverage landscapes. This policy watch reviews what we know and outlines key questions to watch for regarding employment and coverage outcomes. We continue to follow the research on who is most at risk of long COVID and whether there are interventions that can reduce its incidence, length, or severity.
This analysis examines monkeypox vaccine allocations and jurisdictional requests. It explores jurisdictional request rate (the number of vaccine does requested as a share of the jurisdiction’s allocation from HHS) for JYNNEOS, the preferred vaccine. Overall, while most jurisdictions have requested at least their full supply, some are well below that mark, raising questions about how quickly their at-risk populations can get protected.
Addressing the cost of insulin continues to be at the forefront of policy discussions around prescription drugs. This analysis describes out-of-pocket spending on insulin products by Medicare beneficiaries enrolled in Part D drug plans, along with state-level use and spending data.
Update: The Number of People Not Up to Date on Vaccination in Counties with Elevated COVID-19 Community Levels is Growing
This post provides updated estimates the number of people who are not up-to-date on COVID-19 vaccination living in counties designated by the CDC as being “high” or “medium” COVID-19 community levels. These are areas of elevated risk, with relatively high levels of new COVID-19 cases and strained hospital capacity. This analysis finds that the number of those not up to date on COVID-19 vaccination, and the most at risk for severe illness, living in areas of elevated risk has grown since early June 2022.
How Would the Prescription Drug Provisions in the Senate Reconciliation Proposal Affect Medicare Beneficiaries?
The brief provides a quick explainer of the prescription drug provisions in legislative text released by the Senate Finance Committee to be included in a forthcoming reconciliation bill and presents new estimates on how many Medicare beneficiaries could be helped by those provisions.